Company record
Artivion, Inc
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Artivion, Inc.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Artivion, Inc Device |
CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010 A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded. |